Monthly Archives: January 2015

Researchers discuss challenges in reporting trial results

In a new study in the journal Trials, 59 researchers were interviewed about their experiences running clinical trials and getting their results published. Many of the researchers talked about the challenges they faced in getting results published: for example, negative or unclear results, a lack of time or resources or rejection by journals. About half […]

28th January 2015|

EMA consults on implementing transparency measures

The European Medicines Agency (EMA) is seeking feedback on how to implement the new Clinical Trials Regulation. This is the law that the European Parliament passed in April following all of your support for its strong transparency measures.

We are currently preparing our response and as soon as that’s ready, we’ll share it with you.

You can read the […]

23rd January 2015|

Half of all trials remain unpublished

A new systematic review has found that only 53% of clinical trials are published in journal articles. The review included 39 studies which looked at how many trials were published after being entered on a clinical trial database or approved by an ethics committee. The authors of the review also found that trials with positive findings were three times more likely […]

20th January 2015|

British Tinnitus Association joins AllTrials and fights for access to results of a trial

The British Tinnitus Association (BTA) joined AllTrials saying:
The BTA is the only national charity dedicated to supporting the 10% of the UK adult population who experience tinnitus. We are a world leader in providing support and advice about tinnitus, giving accurate, reliable and authoritative information. If we are to retain our confidence in the advice […]

19th January 2015|

America’s Institute of Medicine says sharing data from clinical trials should “become the norm”

A new report from the US’s Institute of Medicine says sharing of data from clinical trials is in the public interest and should be an integral part of carrying out a clinical trial. The report calls on clinical trial funders, pharmaceutical companies, patient groups, ethics committees, journals and professional bodies to make this happen.

The report concludes that […]

14th January 2015|

How an abandoned heart drug trial was published 13 years later

John Hampton tells the story of how he got a clinical trial published after 13 years. In 1980, he led a trial that investigated the heart drug lorcainide. More of the people in the trial who were given lorcainide died than people in the trial taking the placebo. Because it wasn’t published and doctors didn’t […]

9th January 2015|